Inventor
FULLER PETER H
US13 patents
⚠️ This page may combine multiple inventors who share the name “FULLER PETER H”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK SHARP & DOHME
6 patentsUS10287272B2May 14, 2019
Substituted indazole compounds as RORgammaT inhibitors and uses thereof
MERCK SHARP & DOHME3 citations72
US10221142B2Mar 5, 2019
Substituted pyrazole compounds as RORgammaT inhibitors and uses thereof
MERCK SHARP & DOHME3 citations71
US11161854B2Nov 2, 2021
Indazolyl-spiro[2.2]pentane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
MERCK SHARP & DOHME2 citations68
US10344000B2Jul 9, 2019
Substituted bicyclic pyrazole compounds as RORgammaT inhibitors and uses thereof
MERCK SHARP & DOHME1 citations60
US10689369B2Jun 23, 2020
Substituted indazole compounds as RORgammaT inhibitors and uses thereof
MERCK SHARP & DOHME0 citations51
US11174248B2Nov 16, 2021
Indazolyl-spiro[2.3]hexane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
MERCK SHARP & DOHME0 citations49
MERCK SHARP & DOHME LLC
5 patentsUS12030872B2Jul 9, 2024
N-heteroaryl indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
MERCK SHARP & DOHME LLC2 citations69
US12319671B2Jun 3, 2025
1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
MERCK SHARP & DOHME LLC0 citations48
US12516039B2Jan 6, 2026
N-linked isoquinoline amides as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
MERCK SHARP & DOHME LLC0 citations47
US12570640B2Mar 10, 2026
2-aminoquinazolines as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
MERCK SHARP & DOHME LLC0 citations46
US12540131B2Feb 3, 2026
N-(heteroaryl) quinazolin-2-amine derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
MERCK SHARP & DOHME LLC0 citations42